ftInvstr
SANOFI · Healthcare ₹3154.0 -1.68% Mkt Cap ₹7260 Cr overvalued

SANOFI

Healthcare Drug Manufacturers - General
₹3154.0
-1.68% today · 30d -5.99%
as of 2026-09-04
Price · Daily Candles
“Sanofi India Faces Steep Declines; Demerger Raises Questions Amidst Profit Slump.”
Sanofi India is trading with a TTM P/E of 23.76, while its 52-week low is ₹3151.6 and close to the current price of ₹3199.00. The company reported a significant YoY decline in Q4 2024 with revenue down 26.67% and net profit down 45.91%. Its valuation score is reasonable at 60, but growth is muted (score 44) and technicals are bearish (score 23).
BULL CASE
+Profitability remains high with a score of 75, despite recent declines, and a current dividend yield of 7.54%.
+Shareholding by FIIs increased by 0.09% QoQ, now standing at 5.64%.
+The institutional risk score is low at 80, suggesting a degree of stability for the ₹7364.0 Cr market cap company.
+The company's P/E of 23.76 is lower than sector peers like GLAXO (37.32) and SANOFICONR (44.71).
BEAR CASE
Top-line and bottom-line figures saw significant year-over-year declines in Q4 2024, with revenue down 26.67% and net profit down 45.91%.
The stock is trading at ₹3199.0, just 1.5% above its 52-week low of ₹3151.6, and 50.09% off its 52-week high of ₹6410.0.
The stock's technical indicators are bearish, with a 'weak' bearish signal from MACD (-4.7609) and a 'moderate' bearish signal from RSI(14) (31.55).
DII shareholding decreased by 0.18% QoQ, now making up 21.13% of total shares.
⟳ What Changed
₹ Latest Earnings · Q ending 2024-09-30
REVENUE
₹524 Cr
-26.67% YoY
NET PROFIT
₹82 Cr
-45.91% YoY
OPM
23.18%
-7.12pp YoY
EPS
₹35.69
PE 23.76
Intrinsic value · DCF ₹1304.83 · Margin of safety -58.6% (overvalued) · FCF yield 5.68%
◇ Sector Position
Sanofi's 23.76 TTM P/E sets it at a discount to peers like Glaxo (37.32) and Sanofi Conr (44.71), while its ROCE is not provided for direct comparison.
PEERPEROCE %
SANOFI23.76
GLAXO37.3260.28
PFIZER29.3925.0
RUBICON119.8940.26
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
52
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation REASONABLE 60
Growth MUTED 44
Profitability HIGH 75
Technicals WEAK 45
Risk LOW 80
Key Stats
TTM PE
23.76
P/B
9.83
52W HIGH
₹5291.0
OFF HIGH
-40.39%
DIV YIELD
7.54%
MKT CAP
₹7260 Cr
◉ Active Signals
MACDBearish-3.867
RSI(14)Neutral40.35
Near 52W LowBearish3.27
Street Consensus
3 analysts
₹4579.0
mean target
Low ₹3700.0Now ₹3154.0High ₹5550.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SANOFI and at what entry.

Sign up freeSign in